BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7848124)

  • 1. Neuropsychological effects of cranial irradiation in young children with acute lymphoblastic leukemia 9 months after diagnosis. The Children's Cancer Group.
    MacLean WE; Noll RB; Stehbens JA; Kaleita TA; Schwartz E; Whitt JK; Cantor NL; Waskerwitz M; Ruymann F; Novak LJ
    Arch Neurol; 1995 Feb; 52(2):156-60. PubMed ID: 7848124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA; Reaman GH; MacLean WE; Sather HN; Whitt JK
    Cancer; 1999 Apr; 85(8):1859-65. PubMed ID: 10223582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation.
    Mulhern RK; Fairclough D; Ochs J
    J Clin Oncol; 1991 Aug; 9(8):1348-56. PubMed ID: 2072138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
    Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate.
    Liu HC; Liang DC; Chen SH; Lo CY; Tseng KP; Kuo TB; Chen HJ; Wang SJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):107-10. PubMed ID: 8935408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.
    Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1993 Mar; 11(3):527-37. PubMed ID: 8445428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia.
    Halberg FE; Kramer JH; Moore IM; Wara WM; Matthay KK; Ablin AR
    Int J Radiat Oncol Biol Phys; 1992; 22(1):13-6. PubMed ID: 1727109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
    Bleyer WA; Coccia PF; Sather HN; Level C; Lukens J; Niebrugge DJ; Siegel S; Littman PS; Leikin SL; Miller DR
    J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.
    Balsom WR; Bleyer WA; Robison LL; Heyn RM; Meadows AT; Sitarz A; Blatt J; Sather HN; Hammond GD
    Med Pediatr Oncol; 1991; 19(6):486-92. PubMed ID: 1961135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cranial computed tomography in children with acute lymphoblastic leukemia after prophylactic treatment with cranial radiation therapy and intrathecal methotrexate.
    Liang DC; Lin JC; Shih SL; Huang JK; Wong LY; Shu SG; Hsieh YL; Yang CP; Tsai YM; Lin ST
    Cancer; 1993 Mar; 71(6):2105-8. PubMed ID: 8443759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group.
    Hertzberg H; Huk WJ; Ueberall MA; Langer T; Meier W; Dopfer R; Skalej M; Lackner H; Bode U; Janssen G; Zintl F; Beck JD
    Med Pediatr Oncol; 1997 Jun; 28(6):387-400. PubMed ID: 9143382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation.
    Précourt S; Robaey P; Lamothe I; Lassonde M; Sauerwein HC; Moghrabi A
    Dev Neuropsychol; 2002; 21(2):173-95. PubMed ID: 12139198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group.
    Bleyer WA; Fallavollita J; Robison L; Balsom W; Meadows A; Heyn R; Sitarz A; Ortega J; Miller D; Constine L
    Pediatr Hematol Oncol; 1990; 7(4):329-38. PubMed ID: 2268533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.